Atlas Trials

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Clinical trial NCT04203056 · TERMINATED

Trial details

NCT number
NCT04203056
Sponsor
University of California, Los Angeles
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder, Depressive TypeSchizophreniform Disorder
Start date
2019-12-16
Primary completion
2022-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.